Protamine 2 deficiency results in Septin 12 abnormalities
There is a well-established link between abnormal sperm chromatin states and poor motility, however, how these two processes are interdependent is unknown. Here, we identified a possible mechanistic insight by showing that Protamine 2, a nuclear DNA packaging protein in sperm, directly interacts with cytoskeletal protein Septin 12, which is associated with sperm motility. Septin 12 has several isoforms, and we show, that in the <i>Prm2</i> <sup><i>-/-</i></sup> sperm, the short one (Mw 36 kDa) is mis-localized, while two long isoforms (Mw 40 and 41 kDa) are unexpectedly lost in <i>Prm2</i> <sup><i>-/-</i></sup> sperm chromatin-bound protein fractions. Septin 12 co-immunoprecipitated with Protamine 2 in the testicular cell lysate of WT mice and with Lamin B1/2/3 in co-transfected HEK cells despite we did not observe changes in Lamin B2/B3 proteins or SUN4 expression in <i>Prm2</i> <sup><i>-/-</i></sup> testes. Furthermore, the <i>Prm2</i> <sup><i>-/-</i></sup> sperm have on average a smaller sperm nucleus and aberrant acrosome biogenesis. In humans, patients with low sperm motility (asthenozoospermia) have imbalanced histone-protamine 1/2 ratio, modified levels of cytoskeletal proteins and we detected retained Septin 12 isoforms (Mw 40 and 41 kDa) in the sperm membrane, chromatin-bound and tubulin/mitochondria protein fractions. In conclusion, our findings present potential interaction between Septin 12 and Protamine 2 or Lamin B2/3 and describe a new connection between their expression and localization, contributing likely to low sperm motility and morphological abnormalities.
Authors
- Hubert Schorle (ORCID: https://orcid.org/0000-0001-8272-0076)
- Kateřina Komrsková (ORCID: https://orcid.org/0000-0002-6837-2148)
- Klaus Steger (ORCID: https://orcid.org/0000-0002-2104-0840)
- Jana Vondráková (ORCID: https://orcid.org/0000-0001-5615-6221)
- Lindsay Moritz (ORCID: https://orcid.org/0000-0001-6704-8453)
- Saher Sue Hammoud (ORCID: https://orcid.org/0000-0002-5040-6370)
- Tomer Avidor‐Reiss (ORCID: https://orcid.org/0000-0003-0918-526X)
- Michaela Frolíková (ORCID: https://orcid.org/0000-0002-9834-8405)
- Veronika Kraus (ORCID: https://orcid.org/0000-0001-7712-2688)
- Maryam Qasemi (ORCID: https://orcid.org/0000-0002-0723-0445)
- František Liška (ORCID: https://orcid.org/0000-0002-9588-806X)
- Lukáš Děd (ORCID: https://orcid.org/0000-0003-1053-4025)
- Pavla Postlerová (ORCID: https://orcid.org/0000-0002-5090-4652)
- Daniela Spevakova
- Ondřej Šimoník (ORCID: https://orcid.org/0000-0002-6577-765X)
- Drew Lewis Caswell (ORCID: https://orcid.org/0009-0007-8735-3296)
- Ondrej Sanovec (ORCID: https://orcid.org/0000-0003-3040-6602)
Institutions
- Justus-Liebig-Universität Gießen (DE)
- Charles University (CZ)
- University of Michigan (US)
- University Hospital Bonn (DE)
- Czech Academy of Sciences, Institute of Biotechnology (CZ)
- General University Hospital in Prague (CZ)
- University of Toledo (US)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3389/fcell.2024.1447630
- Citations
- 2
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.76
Funders
- Deutsche Forschungsgemeinschaft
- Grantová Agentura České Republiky
- Akademie Věd České Republiky